Skip to main content
ES
v1.2
Log in
A

Abbott India

ABBOTT INDIANSE
₹26,170+100.00 (+0.38%)as of 2026-10-16
Market Cap
₹55,678Cr.
P/E Ratio
34.5
P/B Ratio
11.65
EPS (TTM)
₹758.55
Day Range
₹25,910 – ₹26,230
Div Yield
2.04%
ROCE
44.8%
ROE
34.4%
52W Low: ₹25,13552W High: ₹30,655
Themes:💊 Pharma & CDMO
Appears in 1 screen
🏆Quality Compounders
89
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 9.0% a year over three years.
  • Debt is 0.04× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Abbott_India — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
6/ 10Overall
5/ 10Valuation
9/ 10Quality
5/ 10Fundamental
5/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 34.5P/E: 34.5 | P/B: 11.65
Growth
ModestSales CAGR — 3Y: 9% · 1Y: 6%
Profitability
High MarginROCE: 44.8% | ROE: 34.4%

Key Metrics

Valuation
PEG Ratio 1.92
Price / Sales 7.95x
Price / FCF 42.6x
Book Value ₹2247
Margins & returns
Operating Margin 28%
Net Margin 23.1%
Return on Assets 24.8%

Frequently Asked Questions

MarketsPortfolioChart